National Glycoengineering Research Center, NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao 266237, China.
National Glycoengineering Research Center, NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao 266237, China.
Carbohydr Polym. 2024 Nov 1;343:122492. doi: 10.1016/j.carbpol.2024.122492. Epub 2024 Jul 16.
Effective wound care remains a significant challenge due to the need for infection prevention, inflammation reduction, and minimal tissue damage during dressing changes. To tackle these issues, we have developed a multifunctional hydrogel (CHI/CPBA/RU), composed of chitosan (CHI) modified with 4-carboxyphenylboronic acid (CPBA) and the natural flavonoid, rutin (RU). This design endows the hydrogel with body temperature-responsive adhesion and low temperature-triggered detachment, thus enabling painless removal during dressing changes. The CHI/CPBA/RU hydrogels exhibit excellent biocompatibility, maintaining over 97 % viability of L929 cells. They also demonstrate potent intracellular free radical scavenging activity, with scavenging ratios ranging from 53 % to 70 %. Additionally, these hydrogels show anti-inflammatory effects by inhibiting pro-inflammatory cytokines (TNF-α, IL-6, and iNOS) and increasing anti-inflammatory markers (Arg1 and CD206) in RAW 264.7 macrophages. Notably, they possess robust antimicrobial properties, inhibiting over 99.9 % of the growth of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus growth. In vivo testing on a murine full-thickness skin defect model shows that the hydrogel significantly accelerates wound healing by reducing inflammation, increasing collagen deposition, and promoting angiogenesis, achieving 98 % healing by day 10 compared to 78 % in the control group. These attributes make the polysaccharide-based hydrogel a promising material for advanced wound care.
由于需要在换药时预防感染、减轻炎症和尽量减少组织损伤,有效的伤口护理仍然是一个重大挑战。为了解决这些问题,我们开发了一种多功能水凝胶(CHI/CPBA/RU),由经过 4-羧基苯硼酸(CPBA)修饰的壳聚糖(CHI)和天然黄酮芦丁(RU)组成。这种设计使水凝胶具有体温响应性粘附性和低温触发脱离性,从而实现换药时无痛去除。CHI/CPBA/RU 水凝胶具有出色的生物相容性,保持 L929 细胞超过 97%的活力。它们还表现出强大的细胞内自由基清除活性,清除率在 53%至 70%之间。此外,这些水凝胶通过抑制促炎细胞因子(TNF-α、IL-6 和 iNOS)和增加抗炎标志物(Arg1 和 CD206)在 RAW 264.7 巨噬细胞中表现出抗炎作用。值得注意的是,它们具有强大的抗菌性能,抑制大肠杆菌、铜绿假单胞菌和金黄色葡萄球菌生长超过 99.9%。在小鼠全层皮肤缺损模型中的体内测试表明,水凝胶通过减少炎症、增加胶原蛋白沉积和促进血管生成,显著加速伤口愈合,与对照组相比,第 10 天达到 98%的愈合率,而对照组为 78%。这些特性使基于多糖的水凝胶成为先进伤口护理的有前途的材料。